HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
50 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PARP1
poly(ADP-ribose) polymerase 1
Chromosome 1 · 1q42.12
NCBI Gene: 142Ensembl: ENSG00000143799.15HGNC: HGNC:270UniProt: P09874
1,590PubMed Papers
20Diseases
13Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
ApoptosisDNA RepairHub GeneTranscription Factor
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
DNA damage responsemitochondrion organizationmitochondrial DNA metabolic processregulation of protein localizationovarian cancerneoplasmbreast cancerovarian carcinoma
✦AI Summary

PARP1 (poly(ADP-ribose) polymerase 1) is a nuclear DNA damage sensor that catalyzes the synthesis of poly(ADP-ribose) (PAR) chains from NAD+ upon binding to DNA breaks and non-B DNA structures 1. The enzyme functions through co-condensation with DNA at double-strand break sites, exerting mechanical forces to maintain DNA end synapsis and becoming enzymatically active for PAR synthesis 2. PARP1 also associates with R-loops to promote their resolution and prevent genomic instability 3. Beyond DNA repair, PARP1 interacts with chr1 regulatory complexes like WDR5 to facilitate target gene recognition and transcriptional regulation 4. In cell death pathways, PARP1 plays dual roles: excessive PAR production leads to parthanatos, a caspase-independent programmed cell death 5, while caspase cleavage of PARP1 generates an 89-kDa fragment that serves as a cytoplasmic PAR carrier, facilitating AIF-mediated apoptosis 6. PARP1 also regulates mitochondrial homeostasis through interactions with POLG and UCP2, affecting mitochondrial DNA synthesis and oxidative phosphorylation 7. The protein's regulation involves E3 ubiquitin ligases like RNF114, which target PARP1 for degradation to prevent excessive trapping at DNA lesions 8.

Sources cited
1
PARP1 catalyzes PAR synthesis from NAD+ upon DNA damage
PMID: 30799503
2
PARP1 co-condenses with DNA at break sites to maintain DNA end synapsis
PMID: 38320550
3
PARP1 binds R-loops and prevents genomic instability
PMID: 36794853
4
PARP1 interacts with WDR5 for chromatin recognition and gene regulation
PMID: 38750719
5
PARP1 mediates parthanatos, a caspase-independent cell death
PMID: 38088577
6
89-kDa PARP1 cleavage fragment acts as cytoplasmic PAR carrier for AIF-mediated apoptosis
PMID: 33168626
7
PARP1 regulates mitochondrial homeostasis through POLG/UCP2 pathway
PMID: 37679327
8
RNF114 targets PARP1 for degradation to prevent excessive DNA trapping
PMID: 37878693
Disease Associationsⓘ20
ovarian cancerOpen Targets
0.62Moderate
neoplasmOpen Targets
0.60Moderate
breast cancerOpen Targets
0.58Moderate
ovarian carcinomaOpen Targets
0.56Moderate
ovarian neoplasmOpen Targets
0.55Moderate
breast neoplasmOpen Targets
0.54Moderate
prostate cancerOpen Targets
0.53Moderate
peritoneum cancerOpen Targets
0.49Moderate
fallopian tube cancerOpen Targets
0.49Moderate
cutaneous melanomaOpen Targets
0.48Moderate
clonal hematopoiesisOpen Targets
0.47Moderate
Fallopian Tube CarcinomaOpen Targets
0.46Moderate
peritoneal neoplasmOpen Targets
0.46Moderate
pancreatic neoplasmOpen Targets
0.45Moderate
cancerOpen Targets
0.43Moderate
non-small cell lung carcinomaOpen Targets
0.41Moderate
breast carcinomaOpen Targets
0.41Moderate
myeloproliferative disorderOpen Targets
0.41Moderate
melanomaOpen Targets
0.38Weak
influenzaOpen Targets
0.38Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets13
2X-121Phase II
Tankyrase 1/2 inhibitor
breast cancer
AMELPARIB DIHYDROCHLORIDE DIHYDRATEPhase II
Poly [ADP-ribose] polymerase-1 inhibitor
Ischemic stroke
E-7016Phase II
PARP 1, 2 and 3 inhibitor
melanoma
NIRAPARIBApproved
Poly [ADP-ribose] polymerase 2 inhibitor
NIRAPARIB TOSYLATE MONOHYDRATEApproved
Poly [ADP-ribose] polymerase 2 inhibitor
ovarian cancer
OLAPARIBApproved
PARP 1, 2 and 3 inhibitor
ovarian cancer
PAMIPARIBApproved
Poly [ADP-ribose] polymerase 2 inhibitor
neoplasm
RUCAPARIBApproved
PARP 1, 2 and 3 inhibitor
ovarian cancer
RUCAPARIB CAMSYLATEApproved
PARP 1, 2 and 3 inhibitor
ovarian cancer
SENAPARIBPhase II
Poly [ADP-ribose] polymerase 2 inhibitor
ovarian cancer
TALAZOPARIBApproved
Poly [ADP-ribose] polymerase-1 inhibitor
breast cancer
TALAZOPARIB TOSYLATEApproved
Poly [ADP-ribose] polymerase-1 inhibitor
breast cancer
VELIPARIBApproved
PARP 1, 2 and 3 inhibitor
neoplasm
Related Genes
XRCC1Protein interaction100%TP53BP1Protein interaction100%HPF1Protein interaction100%RELAProtein interaction100%POLQProtein interaction100%POLBProtein interaction100%
Tissue Expression6 tissues
Brain
100%
Heart
63%
Bone Marrow
30%
Liver
29%
Lung
23%
Ovary
21%
Gene Interaction Network
Click a node to explore
PARP1XRCC1TP53BP1HPF1RELAPOLQPOLB
PROTEIN STRUCTURE
Preparing viewer…
PDB6NRH · 1.50 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.45Moderately Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.34 [0.26–0.45]
RankingsWhere PARP1 stands among ~20K protein-coding genes
  • #76of 20,598
    Most Researched1,590 · top 1%
  • #166of 1,025
    FDA-Approved Drug Targets9 · top quartile
  • #2,539of 17,882
    Most Constrained (LOEUF)0.45 · top quartile
Genes detectedPARP1
Sources retrieved50 papers
Response time—
📄 Sources
50▼
1
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
PMID: 30799503
Nucleic Acids Res · 2019
1.00
2
Stanniocalcin-1 Promotes PARP1-Dependent Cell Death via JNK Activation in Colitis.
PMID: 38088577
Adv Sci (Weinh) · 2024
0.90
3
The PARP1-EXD2 axis orchestrates R-loop resolution to safeguard genome stability.
PMID: 40579572
Nat Chem Biol · 2026
0.88
4
PARP enzyme de novo synthesis of protein-free poly(ADP-ribose).
PMID: 39536748
Mol Cell · 2024
0.86
5
The complex universe of inactive PARP1.
PMID: 39306519
Trends Genet · 2024
0.84